To extend our studies into an animal model, we examined the role of PKM2 K433 acetylation in regulating the growth of TSP50-induced tumors in immune-deficient mice in vivo and assayed for tumor formation (n = 6/group). The gene discussed is PRSS50; the disease is neoplasm.